UC San Francisco @UCSF · 01 Sep 2026
The first personalized cancer vaccine to succeed in a late-stage trial was tested at UCSF. Earlier results showed it cut the risk of melanoma returning by nearly half. UCSF’s Adil Daud, MD, says it could work for other cancers too. https://t.co/z27tV8SujI
2 186Views
24Likes
10Reposts
1Replies
1Quotes
3Bookmarks
Is that a lot?
1.17×vs this author's median1 866 views is typical
60Percentile for this authorof 5 recent posts
0.79×vs 10K–100K median2 751 views is typical
2.96%Reachviews ÷ followers
1.65%Engagement rateof viewers reacted